Advanced pediatric psychopharmacology: Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 5, 2010, Pages 449-452

  Young, Lawrence ^a   Coffey, Barbara J ^a,b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CARNITINE; CHLORPROMAZINE; CLONAZEPAM; DIPHENHYDRAMINE; HALOPERIDOL; INSULIN GLARGINE; LITHIUM; METFORMIN; VALPROIC ACID; TRANQUILIZER;

ADOLESCENT; ANAMNESIS; BEDTIME DOSAGE; BIPOLAR DISORDER; BRAIN DISEASE; CASE REPORT; DELUSION; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HUMAN; HYPERAMMONEMIC ENCEPHALOPATHY; MALE; SHORT SURVEY; ARTICLE; CHEMICALLY INDUCED DISORDER; HYPERAMMONEMIA; INSULIN DEPENDENT DIABETES MELLITUS; TOXICITY AND INTOXICATION;

ADOLESCENT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DIABETES MELLITUS, TYPE 1; HUMANS; HYPERAMMONEMIA; MALE; NEUROTOXICITY SYNDROMES; VALPROIC ACID;

EID: 77958552428     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.2052     Document Type: Short Survey

References (12)

1. Braman E, Sham PC: The common genetic liability between schizophrenia and bipolar disorder: A review. Cur Psychiatry Rep 3:332-337, 2001.
2. Elgudin L, Hall Y, Schubert D: Ammonia induced encephalopathy from valproic acid in a bipolar patient: Case report. Intl J. Psychiatry Med 33:91-96, 2003.
3. Elvin-Lewis M: Should we be concerned about herbal remedies. J Ethnopharmacology 75:141-164, 2001.
4. Fajans SS, Bell GI, Polonsky KS: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New Engl J Med 345:971-980, 2001.
5. Fugh-Berman A: Herb-drug interactions. Lancet 355:134-138, 2000.
6. Gidal BE, Inglese CM, Meyer JF, Pitterle MD, Antonopoulos J, Rust RS. Diet-and valproate-induced transient hyperammonemia: Effect of L-carnitine. Pediatr Neurol 16:301-305, 1997.
7. Jones BD, Runikis AM: Interaction of ginseng with phenelzine. J Clin Psychopharmacol 7:201-202, 1987.
8. Lebovitz HE: Metabolic consequences of atypical antipsychotic drugs. Psychiatric Quarterly 74:277-290, 2003.
9. Raskind J, El-Chaar G: The role of carnitine supplementation during valporic acid therapy. Ann Pharmacotherapy 34:630-638, 2000.
10. Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J: Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 114:1-7, 2006.
11. Tovar RT, Petzel RM: Herbal toxicity. Dis Mon 55:592-641, 2009.
12. Verrotti A, Trotta D, Morgese G, Chiarelli F: Valproate-induced hy-perammonemic encephalopathy. Metabolic Brain Dis 17:367-373, 2002.